A Pilot Study of Nonverbal Cues in Videotelecommunicatton

1996 ◽  
Vol 78 (2) ◽  
pp. 555-561
Author(s):  
Derek Scott

With the increasing popularity of low-cost videocommunications systems and their attendant low bandwidth-resolution problems, receivers are likely to experience difficulties in recognising the sender's intended expression and feeling. As an extension of previous work in the area, this pilot study investigated the effects of three forms of degraded imaging (and their combined effects) on the nonverbal aspects of communication for one person. Degraded video messages significantly impaired the meaning of the sender.

2019 ◽  
Author(s):  
Nikki Theofanopoulou ◽  
Katherine Isbister ◽  
Julian Edbrooke-Childs ◽  
Petr Slovák

BACKGROUND A common challenge within psychiatry and prevention science more broadly is the lack of effective, engaging, and scale-able mechanisms to deliver psycho-social interventions for children, especially beyond in-person therapeutic or school-based contexts. Although digital technology has the potential to address these issues, existing research on technology-enabled interventions for families remains limited. OBJECTIVE The aim of this pilot study was to examine the feasibility of in-situ deployments of a low-cost, bespoke prototype, which has been designed to support children’s in-the-moment emotion regulation efforts. This prototype instantiates a novel intervention model that aims to address the existing limitations by delivering the intervention through an interactive object (a ‘smart toy’) sent home with the child, without any prior training necessary for either the child or their carer. This pilot study examined (i) engagement and acceptability of the device in the homes during 1 week deployments; and (ii) qualitative indicators of emotion regulation effects, as reported by parents and children. METHODS In this qualitative study, ten families (altogether 11 children aged 6-10 years) were recruited from three under-privileged communities in the UK. The RA visited participants in their homes to give children the ‘smart toy’ and conduct a semi-structured interview with at least one parent from each family. Children were given the prototype, a discovery book, and a simple digital camera to keep at home for 7-8 days, after which we interviewed each child and their parent about their experience. Thematic analysis guided the identification and organisation of common themes and patterns across the dataset. In addition, the prototypes automatically logged every interaction with the toy throughout the week-long deployments. RESULTS Across all 10 families, parents and children reported that the ‘smart toy’ was incorporated into children’s emotion regulation practices and engaged with naturally in moments children wanted to relax or calm down. Data suggests that children interacted with the toy throughout the duration of the deployment, found the experience enjoyable, and all requested to keep the toy longer. Child emotional connection to the toy—caring for its ‘well-being’—appears to have driven this strong engagement. Parents reported satisfaction with and acceptability of the toy. CONCLUSIONS This is the first known study investigation of the use of object-enabled intervention delivery to support emotion regulation in-situ. The strong engagement and qualitative indications of effects are promising – children were able to use the prototype without any training and incorporated it into their emotion regulation practices during daily challenges. Future work is needed to extend this indicative data with efficacy studies examining the psychological efficacy of the proposed intervention. More broadly, our findings suggest the potential of a technology-enabled shift in how prevention interventions are designed and delivered: empowering children and parents through ‘child-led, situated interventions’, where participants learn through actionable support directly within family life, as opposed to didactic in-person workshops and a subsequent skills application.


2012 ◽  
Vol 21 (2) ◽  
pp. 126-129 ◽  
Author(s):  
Christopher E. Branson ◽  
Anna Maria Barbuti ◽  
Philip Clemmey ◽  
Lisa Herman ◽  
Phintso Bhutia

2013 ◽  
Vol 27 (7) ◽  
pp. 628-637 ◽  
Author(s):  
Kenneth NK Fong ◽  
Nicole YH Yang ◽  
Marko KL Chan ◽  
Dora YL Chan ◽  
Andy FC Lau ◽  
...  

2018 ◽  
Vol 8 (7) ◽  
pp. 134 ◽  
Author(s):  
Daniel Blackburn ◽  
Yifan Zhao ◽  
Matteo De Marco ◽  
Simon Bell ◽  
Fei He ◽  
...  

Background: The incidence of Alzheimer disease (AD) is increasing with the ageing population. The development of low cost non-invasive diagnostic aids for AD is a research priority. This pilot study investigated whether an approach based on a novel dynamic quantitative parametric EEG method could detect abnormalities in people with AD. Methods: 20 patients with probable AD, 20 matched healthy controls (HC) and 4 patients with probable fronto temporal dementia (FTD) were included. All had detailed neuropsychology along with structural, resting state fMRI and EEG. EEG data were analyzed using the Error Reduction Ratio-causality (ERR-causality) test that can capture both linear and nonlinear interactions between different EEG recording areas. The 95% confidence intervals of EEG levels of bi-centroparietal synchronization were estimated for eyes open (EO) and eyes closed (EC) states. Results: In the EC state, AD patients and HC had very similar levels of bi-centro parietal synchronization; but in the EO resting state, patients with AD had significantly higher levels of synchronization (AD = 0.44; interquartile range (IQR) 0.41 vs. HC = 0.15; IQR 0.17, p < 0.0001). The EO/EC synchronization ratio, a measure of the dynamic changes between the two states, also showed significant differences between these two groups (AD ratio 0.78 versus HC ratio 0.37 p < 0.0001). EO synchronization was also significantly different between AD and FTD (FTD = 0.075; IQR 0.03, p < 0.0001). However, the EO/EC ratio was not informative in the FTD group due to very low levels of synchronization in both states (EO and EC). Conclusion: In this pilot work, resting state quantitative EEG shows significant differences between healthy controls and patients with AD. This approach has the potential to develop into a useful non-invasive and economical diagnostic aid in AD.


2020 ◽  
Vol 31 (6) ◽  
Author(s):  
Rostislav Netek ◽  
Tomas Burian ◽  
Martin Macecek
Keyword(s):  

2020 ◽  
Vol 96 (1136) ◽  
pp. 316-320
Author(s):  
James Schuster-Bruce ◽  
Gita Lingam ◽  
Ryan Laurence Love ◽  
Ryan Kerstein

IntroductionThere is a reduction in Foundation trainee applications to speciality training and this is attributed to an administrative job role, with subsequent fears of burnout. This pilot study presents the findings of a real-time self-reporting tool to map a group of Foundation doctors’ elective activities. Self-reporting is efficient, low cost to run and allows for repeated measures and scalability. It aimed to example how a time-map could be used by departments to address any work imbalances and improve both well-being and future workforce planning.MethodFoundation doctors’, at a busy District General Hospital, were asked to contemporaneously report their work activities over an ‘elective’ day. Outcomes measures included the mean duration per task and the time of day these were performed.ResultsNine Foundation doctors’ returned 26 timesheet days. Foundation doctors’ time was split between direct patient tasks (18.2%, 106.8 min per day), indirect patient tasks (72.9%, 428.6 min per day) and personal or non-patient activities. Indirect tasks were the most frequent reason for Foundation doctors leaving late. No clinical experience was recorded at all and only an average of 4% (23.4 min per day) of a Foundation doctors’ time was spent in theatre.ConclusionsThis particular cohort performed a high proportion of indirect tasks. These have been associated with burnout. Time-mapping is a low-cost, acceptable and seemingly scalable way to elucidate a clearer understanding of the type of activities Foundation doctors may perform. This methodology could be used to modernise the traditional Foundation doctor job description.


Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 2843-2843
Author(s):  
Thierry Leblanc ◽  
Isabelle Marie ◽  
Marianne Debre ◽  
Lydie Da Costa ◽  
Pierre Bordigoni ◽  
...  

Abstract Metoclopramide has been shown to be a potential new therapeutic approach for Diamond-Blackfan anemia (DBA) affected individuals and has been hypothetized to stimulate erythropoiesisis through the induction of prolactin release. Among 15 transfusion-dependent patients enrolled in a previous pilot study, 9 completed 16 weeks of treatment, 3 of whom reaching a complete and sustained response (Abkowitz et al, Blood 2002). In order to further assess the drug efficacy we performed a prospective study in patients included in the French DBA registry. Patients over 2 years of age and dependent on regular transfusions were randomized at inclusion either to be treated immediately after a transfusion (Arm B), or 6 weeks later (Arm A), the comparison of these 2 groups aiming to provide a more accurate determination in the delay of response. All patients were prescribed metoclopramide for 16 or 22 weeks: 10 mg x 3/d in adults and 0.2 mg/kg x 3/d in children (weight &lt; 50 kg). Packed Red Blood Cell transfusions were prescribed for hemoglobin values &lt; 80g/L. The definition of response relied on Hb levels, reticulocyte counts, and the intervals between transfusions. Prolactin as well as other hormones levels were assessed. The study was initiated in October 2003. 7 adults and 22 children have been included so far (13F, 16M): 17 in A and 16 in B arms, respectively; 4 additional pts are planned to be included within a month. The treatment had to be prematurely discontinued in 2 pts because of severe side effects: nervous breakdown (8w of treatment) and anaphylaxis (14w of treatment). Other side effects were mild. Most patients complained of asthenia and drowsiness which both decreased after the 1st weeks of treatment; amenorrhoea (2 pts) and bulimia (3 pts) were also observed. No increase in transfusion need occurred. An update of the trial was performed on August 1st: at that time 21 pts had completed at least 16w of treatment. None of them experienced a complete response, as defined by a transfusion independence. In two a partial response, as defined by an increase in the transfusion interval was obtained: In one patient it evolved from 3–4 to 8 w, and in the other from 6–8 to 10–11w. Both are still on treatment. Lastly, it has to be emphasized that the 2 French responder patients previously included in the pilot study are still transfusion independent more than 5 yr after the initiation of metoclopramide treatment. CONCLUSION: metoclopramide may be of interest in some DBA affected individuals, even though we only obtained a low rate of partial responses in the present ongoing trial. We believe that this non toxic, and low cost treatment warrants to be tested in all patients with regular transfusion need or requiring high dose steroids. The duration of response and long term tolerance remain to be determined. Acknowledgments: Maria Daniela Arturi Foundation, DBA foundation and Assistance Publique-Hôpitaux de Paris (DRRC)


2015 ◽  
Vol 156 ◽  
pp. 213-222 ◽  
Author(s):  
Liang Zhang ◽  
Peng Xu ◽  
Jiachen Mao ◽  
Xu Tang ◽  
Zhengwei Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document